The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
The Cytokine Network in Chronic Obstructive Pulmonary Disease
Abstract
Multiple cytokines play a role in the orchestration of inflammation in inflammatory airway diseases, such as chronic obstructive pulmonary disease, through the recruitment, activation and survival of inflammatory cells. Lymphokines secreted from T cells regulate the pattern of inflammation, whereas proinflammatory cytokines amplify and perpetuate the inflammatory response. Multiple chemokines recruit inflammatory cells from the circulation into the lungs and many growth factors maintain this inflammation and lead to characteristic structural changes in the airways. There are several therapeutic approaches that target cytokine-mediated inflammation in chronic obstructive pulmonary disease, but blocking specific cytokines may not provide clinical benefit, whereas broad-spectrum anti-inflammatory approaches are more likely to be clinically effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Self-citationEssential autocrine regulation by IL-21 in the generation of inflammatory T cells
Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K., Tian, Q., Watowich, S. S., Jetten, A. M., et al. (2007) · Nature · doi:10.1038/nature05969 · Cited by 1,466
Immunology of asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2254 · Cited by 1,399
Self-citationKeatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564092 · Cited by 1,362
Self-citationMepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Kasahara, Y., Tuder, R. M., Taraseviciene-Stewart, L., Le Cras, T. D., Abman, S., Hirth, P. K., Waltenberger, J., & Voelkel, N. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10259 · Cited by 1,112
The cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982
Self-citationVolpe, E., Servant, N., Zollinger, R., Bogiatzi, S. I., Hupé, P., Barillot, E., & Soumelis, V. (2008) · Nature Immunology · doi:10.1038/ni.1613 · Cited by 938
Immunologic Aspects of Chronic Obstructive Pulmonary Disease
Cosio, M. G., Saetta, M., & Agusti, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804752 · Cited by 815
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Bhowmik, A. (2000) · Thorax · doi:10.1136/thorax.55.2.114 · Cited by 730
Mediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Self-citationLiu, Y.-J., Soumelis, V., Watanabe, N., Ito, T., Wang, Y.-H., de Waal Malefyt, R., Omori, M., Zhou, B., & Ziegler, S. F. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141718 · Cited by 659
Chen, Y., Thai, P., Zhao, Y.-H., Ho, Y.-S., DeSouza, M. M., & Wu, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210429200 · Cited by 577
A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation
Weathington, N. M., van Houwelingen, A. H., Noerager, B. D., Jackson, P. L., Kraneveld, A. D., Galin, F. S., Folkerts, G., Nijkamp, F. P., & Blalock, J. E. (2006) · Nature Medicine · doi:10.1038/nm1361 · Cited by 496
AARON, S. D., ANGEL, J. B., LUNAU, M., WRIGHT, K., FEX, C., LE SAUX, N., & DALES, R. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2003122 · Cited by 466
The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
Rennard, S. I., Fogarty, C., Kelsen, S., Long, W., Ramsdell, J., Allison, J., Mahler, D., Saadeh, C., Siler, T., Snell, P., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-995oc · Cited by 439
Ying, S., O’Connor, B., Ratoff, J., Meng, Q., Fang, C., Cousins, D., Zhang, G., Gu, S., Gao, Z., Shamji, B., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2790 · Cited by 402
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
Feldmann, M., & Maini, S. R. N. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00626.x · Cited by 381
TAKIZAWA, H., TANAKA, M., TAKAMI, K., OHTOSHI, T., ITO, K., SATOH, M., OKADA, Y., YAMASAWA, F., NAKAHARA, K., & UMEDA, A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.6.9908135 · Cited by 378
Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD
Traves, S. L. (2002) · Thorax · doi:10.1136/thorax.57.7.590 · Cited by 377
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Majo, J., Ghezzo, H., & Cosio, M. G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17509460 · Cited by 374
Saetta, M., Mariani, M., Panina-Bordignon, P., Turato, G., Buonsanti, C., Baraldo, S., Bellettato, C. M., Papi, A., Corbetta, L., Zuin, R., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107139 · Cited by 372
The IL-12 Family of Cytokines in Infection, Inflammation and Autoimmune Disorders
Gee, K., Guzzo, C., Che Mat, N., Ma, W., & Kumar, A. (2009) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152809787582507 · Cited by 356
Qiu, Y., Zhu, J., Bandi, V., Atmar, R. L., Hattotuwa, K., Guntupalli, K. K., & Jeffery, P. K. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-794oc · Cited by 351
Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the Mouse
Churg, A., Wang, R. D., Tai, H., Wang, X., Xie, C., & Wright, J. L. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-511oc · Cited by 348
PDE4 inhibitors: current status
Spina, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.307 · Cited by 340
Di Stefano, A., Caramori, G., Gnemmi, I., Contoli, M., Vicari, C., Capelli, A., Magno, F., D'Anna, S. E., Zanini, A., Brun, P., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03965.x · Cited by 336
Self-citationCulpitt, S. V., Rogers, D. F., Shah, P., De Matos, C., Russell, R. E. K., Donnelly, L. E., & Barnes, P. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-298oc · Cited by 333
Self-citationNing, W., Li, C.-J., Kaminski, N., Feghali-Bostwick, C. A., Alber, S. M., Di, Y. P., Otterbein, S. L., Song, R., Hayashi, S., Zhou, Z., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401168101 · Cited by 328
Gaggar, A., Jackson, P. L., Noerager, B. D., O’Reilly, P. J., McQuaid, D. B., Rowe, S. M., Clancy, J. P., & Blalock, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5662 · Cited by 325
The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29
Commins, S., Steinke, J. W., & Borish, L. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.02.026 · Cited by 321
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
Self-citationde BOER, W. I., van SCHADEWIJK, A., SONT, J. K., SHARMA, H. S., STOLK, J., HIEMSTRA, P. S., & van KRIEKEN, J. H. J. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9803053 · Cited by 314
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD
de Boer, W. I., Sont, J. K., van Schadewijk, A., Stolk, J., van Krieken, J. H., & Hiemstra, P. S. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200004)190:5<619::aid-path555>3.0.co;2-6 · Cited by 306
Grootendorst, D. C., Gauw, S. A., Verhoosel, R. M., Sterk, P. J., Hospers, J. J., Bredenbroker, D., Bethke, T. D., Hiemstra, P. S., & Rabe, K. F. (2007) · Thorax · doi:10.1136/thx.2006.075937 · Cited by 286
TH17 cells in the big picture of immunology
Schmidt-Weber, C. B., Akdis, M., & Akdis, C. A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.039 · Cited by 269
Increased activation of p38 MAPK in COPD
Renda, T., Baraldo, S., Pelaia, G., Bazzan, E., Turato, G., Papi, A., Maestrelli, P., Maselli, R., Vatrella, A., Fabbri, L. M., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00036707 · Cited by 257
Shao, M. X. G., & Nadel, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.4009 · Cited by 230
Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers
Takanashi, S., Hasegawa, Y., Kanehira, Y., Yamamoto, K., Fujimoto, K., Satoh, K., & Okamura, K. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14b12.x · Cited by 228
Relationship of Epidermal Growth Factor Receptors to Goblet Cell Production in Human Bronchi
TAKEYAMA, K., FAHY, J. V., & NADEL, J. A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2001038 · Cited by 219
CXCR2 antagonists for the treatment of pulmonary disease
Chapman, R. W., Phillips, J. E., Hipkin, R. W., Curran, A. K., Lundell, D., & Fine, J. S. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.005 · Cited by 214
ZHU, J., QIU, Y. S., MAJUMDAR, S., GAMBLE, E., MATIN, D., TURATO, G., FABBRI, L. M., BARNES, N., SAETTA, M., & JEFFERY, P. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2007050 · Cited by 203
The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research
Curtis, J. L., Freeman, C. M., & Hogg, J. C. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-002fm · Cited by 192
Culpitt, S. V., de Matos, C., Russell, R. E., Donnelly, L. E., Rogers, D. F., & Barnes, P. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105106 · Cited by 181
Self-citationCigarette Smoke Drives Small Airway Remodeling by Induction of Growth Factors in the Airway Wall
Churg, A., Tai, H., Coulthard, T., Wang, R., & Wright, J. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-585oc · Cited by 173
High levels of interleukin-6 in the exhaled breath condensate of patients with COPD
Bucchioni, E., Kharitonov, S. A., Allegra, L., & Barnes, P. J. (2003) · Respiratory Medicine · doi:10.1016/j.rmed.2003.07.008 · Cited by 168
Self-citationIL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease
Calabrese, F., Baraldo, S., Bazzan, E., Lunardi, F., Rea, F., Maestrelli, P., Turato, G., Lokar-Oliani, K., Papi, A., Zuin, R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-646oc · Cited by 167
IL-21: An Executor of B Cell Fate
Konforte, D., Simard, N., & Paige, C. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803009 · Cited by 165
CXCR3 and CCR5 Chemokines in Induced Sputum From Patients With COPD
Costa, C., Rufino, R., Traves, S. L., Lapa e Silva, J. R., Barnes, P. J., & Donnelly, L. E. (2008) · Chest · doi:10.1378/chest.07-0393 · Cited by 165
Self-citationZhang, K., Shan, L., Rahman, M. S., Unruh, H., Halayko, A. J., & Gounni, A. S. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00045.2007 · Cited by 162
Gene Expression Profiling in Patients with Chronic Obstructive Pulmonary Disease and Lung Cancer
Wang, I.-M., Stepaniants, S., Boie, Y., Mortimer, J. R., Kennedy, B., Elliott, M., Hayashi, S., Loy, L., Coulter, S., Cervino, S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-390oc · Cited by 160
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Stefano, A. D., Caramori, G., Capelli, A., Gnemmi, I., Ricciardolo, F. L. M., Oates, T. M., Donner, C. F., Chung, K. F., Barnes, P. J., & Adcock, I. M. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00080303 · Cited by 159
Self-citationMucin expression in peripheral airways of patients with chronic obstructive pulmonary disease
Caramori, G., Di Gregorio, C., Carlstedt, I., Casolari, P., Guzzinati, I., Adcock, I. M., Barnes, P. J., Ciaccia, A., Cavallesco, G., Chung, K. F., et al. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01952.x · Cited by 159
Self-citationHardaker, E. L., Bacon, A. M., Carlson, K., Roshak, A., Foley, J. J., Schmidt, D. B., Buckley, P. T., Comegys, M., Panettieri, R. A., Sarau, H. M., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0170fje · Cited by 145
Kanazawa, H., Asai, K., Hirata, K., & Yoshikawa, J. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01562-0 · Cited by 144
Interleukin-18 production and pulmonary function in COPD
Imaoka, H., Hoshino, T., Takei, S., Kinoshita, T., Okamoto, M., Kawayama, T., Kato, S., Iwasaki, H., Watanabe, K., & Aizawa, H. (2007) · European Respiratory Journal · doi:10.1183/09031936.00019207 · Cited by 140
Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
Donnelly, L., & Barnes, P. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.001 · Cited by 137
Self-citationHackett, T., Holloway, R. A., Holgate, S. T., & Warner, J. A. (2008) · Respiratory Research · doi:10.1186/1465-9921-9-47 · Cited by 122
de Boer, W. I., Hau, C. M., van Schadewijk, A. M., Stolk, J. N., van Krieken, J. H. J. M., & Hiemstra, P. S. (2005) · American Journal of Clinical Pathology · doi:10.1309/w1ax-kgt7-ua37-x257 · Cited by 120
Emerging Pharmacotherapies for COPD
Barnes, P. J. (2008) · CHEST Journal · doi:10.1378/chest.08-1385 · Cited by 117
Self-citationCytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease
Barczyk, A., Pierzchała, W., Kon, O. M., Cosío, B. G., Adcock, I. M., & Barnes, P. J. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.013 · Cited by 114
Self-citationBalbi, B., Bason, C., Balleari, E., Fiasella, F., Pesci, A., Ghio, R., & Fabiano, F. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10040846 · Cited by 111
Is Alveolar Destruction and Emphysema in Chronic Obstructive Pulmonary Disease an Immune Disease?
Taraseviciene-Stewart, L., Douglas, I. S., Nana-Sinkam, P. S., Lee, J. D., Tuder, R. M., Nicolls, M. R., & Voelkel, N. F. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-105sf · Cited by 109
Regulatory T Cells, Transforming Growth Factor–β, and Immune Suppression
Wan, Y. Y., & Flavell, R. A. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-020aw · Cited by 106
Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD
Sapey, E., Ahmad, A., Bayley, D., Newbold, P., Snell, N. J. C., Rugman, P., & Stockley, R. A. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9286-8 · Cited by 105
Smith, S. J., Fenwick, P. S., Nicholson, A. G., Kirschenbaum, F., Finney‐Hayward, T. K., Higgins, L. S., Giembycz, M. A., Barnes, P. J., & Donnelly, L. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706885 · Cited by 103
Self-citationSelective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor
Wada, Y., Lu, R., Zhou, D., Chu, J., Przewloka, T., Zhang, S., Li, L., Wu, Y., Qin, J., Balasubramanyam, V., et al. (2006) · Blood · doi:10.1182/blood-2006-04-019398 · Cited by 94
Medicherla, S., Fitzgerald, M. F., Spicer, D., Woodman, P., Ma, J. Y., Kapoun, A. M., Chakravarty, S., Dugar, S., Protter, A. A., & Higgins, L. S. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127092 · Cited by 94
Stefano, A. D., Capelli, A., Lusuardi, M., Caramori, G., Balbo, P. E., Ioli, F., Sacco, S., Gnemmi, I., Brun, P., Adcock, I. M., et al. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01098.x · Cited by 89
Self-citationTraves, S. L., & Donnelly, L. (2008) · Current Molecular Medicine · doi:10.2174/156652408785160998 · Cited by 88
Dendritic Cells in Chronic Obstructive Pulmonary Disease
Tsoumakidou, M., Demedts, I., Brusselle, G., & Jeffery, P. K. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1727pp · Cited by 87
Dentener, M. A., Creutzberg, E. C., Pennings, H.-J., Rijkers, G. T., Mercken, E. M., & Wouters, E. F. �. (2008) · Respiration · doi:10.1159/000117386 · Cited by 86
Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease
Petersen, A. M. W., Penkowa, M., Iversen, M., Frydelund-Larsen, L., Andersen, J. L., Mortensen, J., Lange, P., & Pedersen, B. K. (2007) · Lung · doi:10.1007/s00408-007-9000-7 · Cited by 83
Towards Small‐Molecule CXCR3 Ligands with Clinical Potential
Wijtmans, M., Verzijl, D., Leurs, R., de Esch, I. J. P., & Smit, M. J. (2008) · ChemMedChem · doi:10.1002/cmdc.200700365 · Cited by 79
TNF-α antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease
Suissa, S., Ernst, P., & Hudson, M. (2007) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2007.03.003 · Cited by 71
Rovina, N., Dima, E., Gerassimou, C., Kollintza, A., Gratziou, C., & Roussos, C. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.01.011 · Cited by 67
Kelsen, S. G., Aksoy, M. O., Georgy, M., Hershman, R., Ji, R., Li, X., Hurford, M. T., Solomides, C., Chatila, W. M., & Kim, V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1089oc · Cited by 65
Huang, N., Liu, L., Wang, X., Liu, D., Yin, S., & Yang, X. (2008) · DNA and Cell Biology · doi:10.1089/dna.2007.0715 · Cited by 62
Decreased expression of interleukin 13 in human lung emphysema
Boutten, A. (2004) · Thorax · doi:10.1136/thx.2004.025247 · Cited by 36
Cited by
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
Self-citationPolystyrene microplastic particles: In vitro pulmonary toxicity assessment
Dong, C.-D., Chen, C.-W., Chen, Y.-C., Chen, H.-H., Lee, J.-S., & Lin, C.-H. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121575 · Cited by 711
Kirkham, P. A., & Barnes, P. J. (2013) · Chest · doi:10.1378/chest.12-2664 · Cited by 685
Self-citationCellular and molecular mechanisms of asthma and COPD
Barnes, P. J. (2017) · Clinical Science · doi:10.1042/cs20160487 · Cited by 511
Self-citationOxidative stress-based therapeutics in COPD
Barnes, P. J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101544 · Cited by 497
Self-citation
Metadata
- Authors
- Barnes, P. J.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12
- Volume
- 41
- Issue
- 6
- Pages
- 631-638
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2161357018
- Cited by
- 412
- References
- 83
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.